{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:48:23Z","timestamp":1790772503077,"version":"4.1.0"},"publisher-location":"Chichester, UK","reference-count":59,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd001287.pub3","type":"reference-entry","created":{"date-parts":[[2010,2,17]],"date-time":"2010-02-17T14:19:20Z","timestamp":1266416360000},"source":"Crossref","is-referenced-by-count":18,"title":["Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease"],"prefix":"10.1002","author":[{"given":"Phillippa","family":"Poole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter N","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,2,17]]},"reference":[{"key":"10.1002\/14651858.CD001287.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000196540","article-title":"Prevention of acute exacerbations of chronic obstructive bronchitis with carbocysteine lysine salt monohydrate: a multicenter, double-blind, placebo-controlled trial","volume":"63","author":"Allegra","year":"1996","journal-title":"Respiration"},{"issue":"111Suppl","key":"10.1002\/14651858.CD001287.pub3-BIB2|cit2","first-page":"93","article-title":"Long-term oral acetylcysteine in chronic bronchitis. A double-blind controlled study","volume":"61","year":"1980","journal-title":"European Journal of Respiratory Disease"},{"issue":"1","key":"10.1002\/14651858.CD001287.pub3-BIB3|cit3","first-page":"12","article-title":"Effect of oral N-Acetylcysteine in COPD-a randomised controlled trial","volume":"14","author":"Bachh","year":"2007","journal-title":"JK-Practitioner"},{"key":"10.1002\/14651858.CD001287.pub3-BIB4|cit4","first-page":"405","article-title":"Oral acetylcysteine reduces exacerbation rate in chronic bronchitis; report of a trial organized by the Swedish Society for Pulmonary Diseases","volume":"64","author":"Boman","year":"1983","journal-title":"European Journal of Respiratory Disease"},{"key":"10.1002\/14651858.CD001287.pub3-BIB5|cit5","first-page":"155","article-title":"Clinical effectiveness and tolerance of cithiolone in the prophylaxis of acute infective exacerbations in patients suffering from chronic bronchitis","volume":"17","author":"Bontognali","year":"1991","journal-title":"Acta Therapeutica"},{"key":"10.1002\/14651858.CD001287.pub3-BIB6|cit6","first-page":"467","article-title":"Comparison between acetylcysteine and placebo in the long term treatment of chronic bronchitis","volume":"140","author":"Borgia","year":"1981","journal-title":"Gazzetta Medica Italiana"},{"key":"10.1002\/14651858.CD001287.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000194928","article-title":"Effect of long-term treatment with sobrerol on the exacerbations of chronic bronchitis","volume":"50","author":"Castiglioni","year":"1986","journal-title":"Respiration"},{"key":"10.1002\/14651858.CD001287.pub3-BIB8|cit8","first-page":"715","article-title":"Long-term treatment of chronic bronchitis for two years with ambroxol (Mucosolvan) retard capsules. Results of a double blind trial including 180 patients","volume":"42","author":"Cegla","year":"1988","journal-title":"Praxis Klinik der Pneumologie"},{"key":"10.1002\/14651858.CD001287.pub3-BIB9|cit9","first-page":"121","article-title":"I farmaci attivi sul muco nel trattamento di fondo della bronchite cronica","volume":"116","author":"Cremonini","year":"1986","journal-title":"La Clinica Terapeutica"},{"issue":"9470","key":"10.1002\/14651858.CD001287.pub3-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0140-6736(05)66456-2","article-title":"Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial","volume":"365","author":"Decramer","year":"2005","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001287.pub3-BIB11|cit11","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1034\/j.1399-3003.1999.13d22.x","article-title":"N isobutyrylcysteine, a donor of systemic thiols, does not reduce the exacerbation rate in chronic bronchitis","volume":"13","author":"Ekberg-Jansson","year":"1999","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD001287.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/BF00606554","article-title":"A controlled trial of intermittent oral acetylcysteine in the long-term treatment of chronic bronchitis","volume":"9","author":"Grassi","year":"1976","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD001287.pub3-BIB13|cit13","first-page":"17","article-title":"Terapia intervallare con l'associazione carbocisteina-sobrerolo nella profilassi delle riacutizzazioni della bronchite cronica","volume":"48","author":"Grassi","year":"1994","journal-title":"Italian Journal of Chest Disease"},{"issue":"10","key":"10.1002\/14651858.CD001287.pub3-BIB14|cit14","first-page":"395","article-title":"Long-term oral carbocisteine therapy in patients with chronic bronchitis. A double blind trial with placebo control","volume":"39","author":"Grillage","year":"1985","journal-title":"British Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD001287.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0954-6111(05)80337-3","article-title":"Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitis","volume":"88","author":"Hansen","year":"1994","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD001287.pub3-BIB16|cit16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/030006058401200312","article-title":"Efficacy and tolerability of oral acetylcysteine (fabrol) in chronic bronchitis: a double-blind placebo controlled trial","volume":"12","author":"Jackson","year":"1984","journal-title":"Journal of International Medical Research"},{"key":"10.1002\/14651858.CD001287.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pupt.2003.08.004","article-title":"Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomized, multi-center, placebo-controlled study (the AMETHIST trial)","volume":"17","author":"Malerba","year":"2004","journal-title":"Pulmonary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD001287.pub3-BIB18|cit18","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1136\/thx.40.11.832","article-title":"Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction","volume":"40","year":"1985","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD001287.pub3-BIB19|cit19","unstructured":"Meister R Long-term therapy with acetylcysteine retard tablets in patients with chronic bronchitis:a double-blind. placebo controlled study Unpublished source 1986"},{"issue":"4","key":"10.1002\/14651858.CD001287.pub3-BIB20|cit20","first-page":"351","article-title":"Efficacy and tolerability of myrtol standardized in long-term treatment of chronic bronchitis. A double-blind, placebo-controlled study. Study Group Investigators","volume":"49","author":"Meister","year":"1999","journal-title":"Arzneimittelforschung"},{"issue":"4","key":"10.1002\/14651858.CD001287.pub3-BIB21|cit21","first-page":"143","article-title":"The effect of long-term treatment with erdosteine on chronic obstructive pulmonary disease: the equalife study","volume":"30","author":"Moretti","year":"2004","journal-title":"Drugs Under Experimental & Clinical Research"},{"key":"10.1002\/14651858.CD001287.pub3-BIB22|cit22","first-page":"557s","article-title":"Prevention of COPD exacerbations and reduction of health care utilization with erdosteine","volume":"30 (suppl 51)","author":"Moretti","year":"2007","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD001287.pub3-BIB23|cit23","first-page":"381S","article-title":"Long-term administration of N-acetylcysteine reduces the number of acute exacerbation episodes in subjects with chronic obstructive pulmonary disease:report of the BREATHE study","volume":"14 Suppl","author":"Nowak","year":"1999","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD001287.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000195274","article-title":"Ambroxol for the prevention of chronic bronchitis exacerbations:long-term multicenter trial","volume":"51 Suppl 1","author":"Olivieri","year":"1987","journal-title":"Respiration"},{"key":"10.1002\/14651858.CD001287.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0007-0971(87)90182-3","article-title":"Oral fabrol (oral n-acetyl-cysteine) in chronic bronchitis","volume":"81","author":"Parr","year":"1987","journal-title":"British Journal of Diseases of the Chest"},{"issue":"6","key":"10.1002\/14651858.CD001287.pub3-BIB26|cit26","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1159\/000029447","article-title":"N-acetylcysteine reduces the exacerbation rate in patients with moderate to severe COPD","volume":"66","author":"Pela","year":"1999","journal-title":"Respiration"},{"issue":"Suppl","key":"10.1002\/14651858.CD001287.pub3-BIB27|cit27","doi-asserted-by":"crossref","first-page":"24S","DOI":"10.1378\/chest.97.2.24S","article-title":"Summary of the national mucolytic study","volume":"97","author":"Morgan","year":"1990","journal-title":"Chest"},{"key":"10.1002\/14651858.CD001287.pub3-BIB28|cit28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1378\/chest.97.1.75","article-title":"The national mucolytic study: results of a randomized, double-blind, placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis","volume":"97","author":"Petty","year":"1990","journal-title":"Chest"},{"key":"10.1002\/14651858.CD001287.pub3-BIB29|cit29","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1183\/09031936.93.01040351","article-title":"Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis","volume":"1","author":"Rasmussen","year":"1988","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD001287.pub3-BIB30|cit30","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/S0140-6736(08)60869-7","article-title":"Effect of carbocisteine on acute exacerbations of chronic obstructive pulmonary disease (PEACE study): a randomised placebo-controlled trial","volume":"371","author":"Zheng","year":"2008","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001287.pub3-BIB31|cit31","series-title":"European Respiratory Journal","first-page":"58S","article-title":"Effects of N-acetylcysteine treatment during long term oxygen therapy (LTOT) in COPD patients. An open parallel-group study","author":"Baglioni","year":"2001"},{"issue":"4","key":"10.1002\/14651858.CD001287.pub3-BIB32|cit32","first-page":"277","article-title":"Neltenexine tablets in smoking and non-smoking patients with COPD. A double-blind, randomised, controlled study versus placebo","volume":"92","author":"Cattaneo","year":"2001","journal-title":"Minerva Medica"},{"key":"10.1002\/14651858.CD001287.pub3-BIB33|cit33","first-page":"69","article-title":"Mucolytic treatment of chronic bronchitis during two winter periods","volume":"90","author":"Andreasen","year":"1974","journal-title":"Scandinavian Journal of Respiratory Disease"},{"key":"10.1002\/14651858.CD001287.pub3-BIB34|cit34","first-page":"48","article-title":"Mucolytic treatment of chronic bronchitis during two winter periods","volume":"52","author":"Christensen","year":"1971","journal-title":"Scandinavian Journal of Respiratory Disease"},{"key":"10.1002\/14651858.CD001287.pub3-BIB35|cit35","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1378\/chest.70.4.506","article-title":"S-carboxymethylcysteine in the fluidification of sputum and treatment of chronic airway obstruction","volume":"70","author":"Edwards","year":"1976","journal-title":"Chest"},{"issue":"6","key":"10.1002\/14651858.CD001287.pub3-BIB36|cit36","first-page":"356","article-title":"Chronic obstructive lung diseases:the efficacy of cineole","volume":"44","author":"Habich","year":"1994","journal-title":"Therapiewoche"},{"issue":"6","key":"10.1002\/14651858.CD001287.pub3-BIB37|cit37","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1053\/rmed.2001.1066","article-title":"Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease","volume":"95","author":"Kasielski","year":"2001","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD001287.pub3-BIB38|cit38","first-page":"110","article-title":"Treatment of chronic bronchitis with oral acetylcysteine, a double-blind study","volume":"61","author":"Maesen","year":"1980","journal-title":"European Journal of Respiratory Disease"},{"key":"10.1002\/14651858.CD001287.pub3-BIB39|cit39","first-page":"90","article-title":"Assessment of efficacy and tolerability of the oral treatment of ambrosol in patients with chronic bronchitis","volume":"64 Suppl 1","author":"Michnar","year":"1996","journal-title":"Pneumonologia i Alergologia Polska"},{"key":"10.1002\/14651858.CD001287.pub3-BIB40|cit40","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1378\/chest.109.2.348","article-title":"Iodinated glycerol has no effect on pulmonary function, symptom score, or sputum properties in patients with stable chronic bronchitis","volume":"109","author":"Rubin","year":"1996","journal-title":"Chest"},{"key":"10.1002\/14651858.CD001287.pub3-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1111\/j.1532-5415.2007.01373.x","article-title":"Carbocisteine improves quality of life in patients with chronic obstructive pulmonary disease","volume":"55","author":"Tatsumi","year":"2007","journal-title":"JAGS"},{"key":"10.1002\/14651858.CD001287.pub3-BIB42|cit42","series-title":"Proceedings of American Thoracic Society International Conference, May 18-23, 2007, San Francisco, California, USA","first-page":"C97","article-title":"Carbocisteine reduces the frequency of exacerbations in patients with COPD:findings from the PEACE study","author":"Tatsumi","year":"2007"},{"key":"10.1002\/14651858.CD001287.pub3-BIB43|cit43","series-title":"American Journal of Respiratory and Critical Care Medicine","first-page":"A57","article-title":"The mucolytic effect on quality of life in patients with COPD","author":"Velazquez","year":"2001"},{"key":"10.1002\/14651858.CD001287.pub3-BIB44|cit44","unstructured":"Ongoing study"},{"key":"10.1002\/14651858.CD001287.pub3-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/bmj.320.7245.1297","article-title":"Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial","volume":"320","author":"Burge","year":"2000","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001287.pub3-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-2-1","article-title":"Simpson's paradox and calculation of number needed to treat from meta-analysis","volume":"BMC Medical Res","author":"Cates","year":"2002","journal-title":"Bio Med Central"},{"key":"10.1002\/14651858.CD001287.pub3-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1164\/ajrccm.156.6.9612096","article-title":"Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease","volume":"156","author":"Collet","year":"1997","journal-title":"Amercian Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD001287.pub3-BIB48|cit48","series-title":"Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI\/WHO workshop report (Updated 2005, based on a 1998 workshop). NIH Publication No. 2701","author":"Pauwels","year":"2005"},{"issue":"2","key":"10.1002\/14651858.CD001287.pub3-BIB49|cit49","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0149-2918(00)88479-9","article-title":"Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials","volume":"22","author":"Grandjean","year":"2000","journal-title":"Clinical Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD001287.pub3-BIB50|cit50","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/phrs.1999.0647","article-title":"Cost-effectiveness analysis of oral N-acetylcysteine as a preventive treatment in chronic bronchitis","volume":"42","author":"Grandjean","year":"2000","journal-title":"Pharmacology Research"},{"key":"10.1002\/14651858.CD001287.pub3-BIB51|cit51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomised controlled trials: Is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD001287.pub3-BIB52|cit52","doi-asserted-by":"crossref","first-page":"24S","DOI":"10.1378\/chest.97.2_Supplement.24S","article-title":"Summary of the national mucolytic study","volume":"97 Suppl","author":"Morgan","year":"1990","journal-title":"Chest"},{"issue":"7416","key":"10.1002\/14651858.CD001287.pub3-BIB53|cit53","first-page":"775","article-title":"Definition and classification of chronic bronchitis for clinical and epidemiological purposes","volume":"286","year":"1965","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001287.pub3-BIB54|cit54","article-title":"Epidemiology of COPD","volume-title":"Chronic Obstructive Pulmonary Disease","author":"Redline","year":"1991"},{"issue":"2","key":"10.1002\/14651858.CD001287.pub3-BIB55|cit55","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1034\/j.1399-3003.2000.16b12.x","article-title":"The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review","volume":"16","author":"Stey","year":"2000","journal-title":"European Respiratory Journal"},{"issue":"4","key":"10.1002\/14651858.CD001287.pub3-BIB56|cit56","article-title":"The effect of mucolytic agents on exacerbation frequency in chronic bronchitis","author":"Poole","year":"1998","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD001287.pub3-BIB57|cit57","article-title":"Mucolytic agents for chronic bronchitis","author":"Poole","year":"1999","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001287.pub3-BIB58|cit58","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/bmj.322.7297.1271","article-title":"Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease:systematic review","volume":"322","author":"Poole","year":"2001","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD001287.pub3-BIB59|cit59","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001287.pub2","article-title":"Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease","author":"Poole","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD001287.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T08:32:10Z","timestamp":1685435530000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001287.pub3"}},"subtitle":[],"editor":[{"given":"Phillippa","family":"Poole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,2,17]]},"references-count":59,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001287.pub3","relation":{},"subject":[],"published":{"date-parts":[[2010,2,17]]}}}